Entecavir add-on Peg-interferon therapy plays a positive role in reversing hepatic fibrosis in treatment-naïve chronic hepatitis B patients: a prospective and randomized controlled trial.
Chin Med J (Engl)
; 133(14): 1639-1648, 2020 Jul 20.
Article
in En
| MEDLINE
| ID: mdl-32568867
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hepatitis B, Chronic
Type of study:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Chin Med J (Engl)
Year:
2020
Document type:
Article
Affiliation country:
Country of publication: